Vantin and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Vantin (cefpodoxime proxetil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Constipation.

The phase IV clinical study analyzes which people have Weakness when taking Vantin. It is created by eHealthMe based on reports of 775 people who have side effects when taking Vantin from the FDA, and is updated regularly.

What is Vantin?

Vantin has active ingredients of cefpodoxime proxetil. It is often used in sinusitis. eHealthMe is studying from 788 Vantin users. Check the latest studies of Vantin.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 16, 2026

775 people reported to have side effects when taking Vantin.
Among them, 59 people (7.61%) have Weakness.

Among these 59 people:

How long have people been on Vantin when they have Weakness? *

What is the gender of people who have Weakness when taking Vantin? *

female: 79.66 %
male: 20.34 %

What is the age of people who have Weakness when taking Vantin? *

What are other drugs people take besides Vantin? *

What are other side effects people have besides Weakness? *

Dyspnea (difficult or laboured breathing): 23 people, 38.98%
Nausea (feeling of having an urge to vomit): 22 people, 37.29%
Fever: 20 people, 33.90%
Weight Decreased: 16 people, 27.12%
Nausea And Vomiting: 14 people, 23.73%
Fatigue (feeling of tiredness): 14 people, 23.73%
Headache (pain in head): 13 people, 22.03%
Pleural Effusion (water on the lungs): 12 people, 20.34%
Constipation: 11 people, 18.64%
Confusional State: 11 people, 18.64%

What are the existing conditions these people have? *

Constipation: 5 people, 8.47%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 5.08%
Insomnia (sleeplessness): 3 people, 5.08%
Atherosclerosis (disorder of the arteries): 3 people, 5.08%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 5.08%
Cough: 3 people, 5.08%
Stress And Anxiety: 3 people, 5.08%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 5.08%
Metastases To Bone (cancer spreads to bone): 3 people, 5.08%
Hypersensitivity: 3 people, 5.08%

* Approximation only. Some reports may have incomplete information.

Do you take Vantin and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vantin:

Vantin (788 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Vantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,639 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,612 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefpodoxime proxetil (the active ingredients of Vantin) and Vantin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.